High Vista Strategies LLC United Therapeutics Corp Transaction History

High Vista Strategies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $321,618 - $449,527	1,409 New	1,409 $448,000
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $117,983 - $138,269	557 Added 31.97%	2,299 $519,000
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $299,987 - $340,631	-1,462 Reduced 45.63%	1,742 $384,000
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $136,338 - $185,644	-662 Reduced 17.12%	3,204 $891,000
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $84,166 - $101,086	414 Added 11.99%	3,866 $809,000
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $138,973 - $191,706	795 Added 29.92%	3,452 $813,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $599,671 - $772,181	-3,609 Reduced 57.6%	2,657 $477,000
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $66,723 - $78,220	362 Added 6.13%	6,266 $1.35 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $1.06 Million - $1.27 Million	5,904 New	5,904 $1.09 Million

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.